Hyderabad Telangana, India

Subhra Chakrabarti


Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Hyderabad, IN (2007 - 2008)
  • Banjara Hills, IN (2010)

Company Filing History:


Years Active: 2007-2010

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Subhra Chakrabarti: Innovator in Antibody Research

Introduction

Subhra Chakrabarti is a prominent inventor based in Hyderabad, Telangana, India. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for treating hyperproliferative disorders. With a total of 3 patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

One of her latest patents is focused on antibodies that recognize hyperproliferative cells and methods of making and using them. This invention relates to antibodies that bind to antigens associated with hyperproliferating cells. The antibodies developed through this research are particularly useful for treating hyperproliferative disorders, such as neoplasia. This innovative approach has the potential to significantly impact the treatment landscape for various cancers and related conditions.

Career Highlights

Subhra Chakrabarti is currently associated with Shantha West, Inc., where she continues her groundbreaking research. Her work has garnered attention in the scientific community, and she is recognized for her expertise in antibody development.

Collaborations

She collaborates with notable colleagues, including Sonjoy Mukerjee and Mark C Glassy, who contribute to her research endeavors. Their combined expertise enhances the potential for innovative solutions in the field of biotechnology.

Conclusion

Subhra Chakrabarti's contributions to antibody research are noteworthy and have the potential to transform treatment options for hyperproliferative disorders. Her innovative spirit and dedication to science continue to inspire advancements in medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…